Top 5 Health Care Stocks That Should Keep You Up At Night
Portfolio Pulse from Lisa Levin
The article lists five overbought health care stocks, indicating they may be overvalued: Structure Therapeutics Inc. (GPCR), Olink Holding AB (OLK), Intercept Pharmaceuticals, Inc. (ICPT), NextGen Healthcare, Inc. (NXGN), and HealthStream, Inc. (HSTM). Overbought status is determined by the Relative Strength Index (RSI), with values above 70 indicating overbought conditions. The companies have recent news such as acquisition deals, private placements, and earnings reports.
October 26, 2023 | 12:49 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Structure Therapeutics recently released results from a Phase 1b study and announced a private placement of shares. Its RSI value is 79.61, indicating it is overbought.
The overbought status and recent private placement of shares could put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
HealthStream reported a year-over-year increase in third-quarter EPS results. Its RSI value is 78.79, indicating it is overbought.
Despite the positive earnings report, the overbought status could put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Alfasigma agreed to acquire Intercept Pharmaceuticals. Its RSI value is 75.21, indicating it is overbought.
The overbought status and recent acquisition announcement could put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
NextGen Healthcare posted better-than-expected quarterly earnings. Its RSI value is 80.45, indicating it is overbought.
Despite the positive earnings report, the overbought status could put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Thermo Fisher Scientific announced a deal to acquire Olink Holding. Its RSI value is 82.85, indicating it is overbought.
The overbought status and recent acquisition announcement could put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100